Overview

Post-marketing Study to Supplement Data on Safety, Tolerability and Efficacy of Micardis® With Special Emphasis on the Control of Blood Pressure

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This post-marketing surveillance study is designed to supplement under conditions of normal clinical practice data on safety, tolerability and efficacy of Micardis® collected in clinical studies with special emphasis on the control of blood pressure in the morning before intake of the next antihypertensive drug
Details
Lead Sponsor:
Boehringer Ingelheim
Treatments:
Telmisartan